BioNTech SE (BNTX)
96.90
+0.05
(+0.05%)
USD |
NASDAQ |
Oct 02, 16:00
96.90
0.00 (0.00%)
After-Hours: 20:00
BioNTech Max Drawdown (5Y) : 82.24% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 82.24% |
| August 31, 2026 | 82.24% |
| July 31, 2026 | 82.24% |
| June 30, 2026 | 82.24% |
| May 31, 2026 | 82.24% |
| April 30, 2026 | 82.24% |
| March 31, 2026 | 82.24% |
| February 28, 2026 | 82.24% |
| January 31, 2026 | 82.24% |
| December 31, 2025 | 82.24% |
| November 30, 2025 | 82.24% |
| October 31, 2025 | 82.24% |
| September 30, 2025 | 82.24% |
| August 31, 2025 | 82.24% |
| July 31, 2025 | 82.24% |
| June 30, 2025 | 82.24% |
| May 31, 2025 | 82.24% |
| April 30, 2025 | 82.24% |
| March 31, 2025 | 82.24% |
| February 28, 2025 | 82.24% |
| January 31, 2025 | 82.24% |
| December 31, 2024 | 82.24% |
| November 30, 2024 | 82.24% |
| October 31, 2024 | 82.24% |
| September 30, 2024 | 82.24% |
| Date | Value |
|---|---|
| August 31, 2024 | 82.24% |
| July 31, 2024 | 82.15% |
| June 30, 2024 | 81.79% |
| May 31, 2024 | 80.47% |
| April 30, 2024 | 80.47% |
| March 31, 2024 | 79.84% |
| February 29, 2024 | 79.84% |
| January 31, 2024 | 79.40% |
| December 31, 2023 | 79.40% |
| November 30, 2023 | 79.40% |
| October 31, 2023 | 79.40% |
| September 30, 2023 | 77.68% |
| August 31, 2023 | 77.68% |
| July 31, 2023 | 76.75% |
| June 30, 2023 | 76.75% |
| May 31, 2023 | 76.75% |
| April 30, 2023 | 74.94% |
| March 31, 2023 | 73.16% |
| February 28, 2023 | 73.16% |
| January 31, 2023 | 73.16% |
| December 31, 2022 | 73.16% |
| November 30, 2022 | 73.16% |
| October 31, 2022 | 73.16% |
| September 30, 2022 | 72.07% |
| August 31, 2022 | 72.07% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Moderna, Inc. | 95.38% |
| Biodexa Pharmaceuticals Plc | 100.0% |
| Mereo BioPharma Group Plc | 95.13% |
| NuCana Plc | 99.99% |
| MediGene AG | 98.50% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -34.48 |
| Beta (5Y) | 1.243 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 44.88% |
| Historical Sharpe Ratio (5Y) | -0.4912 |
| Historical Sortino (5Y) | -0.8076 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.50% |